Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-16

Clinical Trial Update: Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care [Phase 4]

View source ↗

Summary

Phase 4 trial comparing extended-release versus oral naltrexone for alcohol dependence conducted in primary care; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • extended-release naltrexone (naltrexone)
  • oral naltrexone (naltrexone)

Snippet

Sponsor: NYU Langone Health | Conditions: Alcohol Dependence | Phase 4 | Status: COMPLETED | Results posted: 2020-06-16